首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   202篇
  免费   2篇
  国内免费   3篇
耳鼻咽喉   2篇
基础医学   14篇
口腔科学   1篇
临床医学   43篇
内科学   17篇
皮肤病学   1篇
神经病学   2篇
特种医学   2篇
外科学   2篇
综合类   12篇
预防医学   20篇
眼科学   2篇
药学   85篇
肿瘤学   4篇
  2023年   1篇
  2022年   4篇
  2021年   4篇
  2020年   4篇
  2019年   5篇
  2018年   12篇
  2017年   3篇
  2016年   3篇
  2015年   3篇
  2014年   11篇
  2013年   19篇
  2012年   19篇
  2011年   15篇
  2010年   5篇
  2009年   15篇
  2008年   6篇
  2007年   4篇
  2006年   6篇
  2005年   7篇
  2004年   12篇
  2003年   6篇
  2002年   8篇
  2001年   5篇
  2000年   9篇
  1999年   1篇
  1998年   5篇
  1997年   6篇
  1995年   4篇
  1994年   1篇
  1993年   3篇
  1991年   1篇
排序方式: 共有207条查询结果,搜索用时 78 毫秒
201.
7取代1乙基(2氟乙基)6,8二氟1,4二氢4氧喹啉3羧酸的合成及抗菌活性鄢立刚徐炳祥马振瀛朱艳静杨倩华(沈阳市沈阳军区后勤部军事医学研究所,沈阳110031;上海市第二军医大学药学院中西药研究室,上海2004...  相似文献   
202.
This is the first report of the presence of qepA1 efflux pump gene in Escherichia coli clinical isolate from Argentina, which was associated to other plasmid-mediated quinolone resistance determinants, such as aac(6′)-Ib-cr and qnrB10 and also quinolone resistance determining regions mutations.  相似文献   
203.
204.
淋球菌对环丙氟哌酸的药物敏感度测定   总被引:10,自引:1,他引:10  
为了解我国淋球菌对氟喹诺酮类药物的敏感性,以琼脂稀释法测定了1994年7月~1996年7月由4个城市分离的535株淋球菌对环丙氟哌酸的敏感性,环丙氟哌酸最小抑菌浓度的范围为0.002~〉2mg/L,73株(13.64%)对环丙氟哌酸耐药,49株(9.16%),对环丙氟哌酸敏感。413株(77.19%)为低敏,4个城市对氟喹诺酮耐药的淋球菌的比率介于7.46%~25.55%,耐药菌株比率呈上升趋势,  相似文献   
205.
AIM To evaluate the association between virulence factor status and antibiotic resistance in Helicobacter pylori(H. pylori)-infected patients in Ireland. METHODS DNA was extracted from antral and corpus biopsies obtained from 165 H. pylori-infected patients. Genotyping for clarithromycin and fluoroquinolone-mediating mutations was performed using the Genotype Helico DR assay. cag A and vac A genotypes were investigated using PCR. RESULTS Primary, secondary and overall resistance rates for clarithromycin were 50.5%(n = 53/105), 78.3%(n = 47/60) and 60.6%(n = 100/165), respectively. Primary, secondary and overall resistance rates for fluoroquinolones were 15.2%(n = 16/105) and 28.3%(n = 17/60) and 20%(n = 33/165), respectively. Resistance to both antibiotics was 12.4%(n = 13/105) in treatment-na?ve patients, 25%(n = 15/60) in those previously treated and 17%(n = 28/165) overall. A cag A-positive genotype was detected in 22.4%(n = 37/165) of patient samples. The dominant vac A genotype was S1/M2 at 44.8%(n = 74/165), followed by S2/M2 at 26.7%(n = 44/165), S1/M1 at 23.6%(n = 39/165) and S2/M1 at 4.8%(n = 8/165). Primary clarithromycin resistance was significantly lower in cag A-positive strains than in cag A-negative strains [32%(n = 8/25) vs 56.3%(n = 45/80); P = 0.03]. Similarly, in patients infected with more virulent H. pylori strains bearing the vac A s1 genotype, primary clarithromycin resistance was significantly lower than in those infected with less virulent strains bearing the vac A s2 genotype, [41%(n = 32/78) vs 77.8%(n = 21/27); P = 0.0001]. No statistically significant association was found between primary fluoroquinolone resistance and virulence factor status.CONCLUSION Genotypic H. pylori clarithromycin resistance is high and cag A-negative strains are dominant in our population. Less virulent(cag A-negative and vac A S2-containing) strains of H. pylori are associated with primary clarithromycin resistance.  相似文献   
206.
马辉 《黑龙江医药》2013,26(4):575-576
目的:观察盐酸洛美沙星软膏的抗菌作用,为临床用药提供科学依据。方法:体外抗菌试验通过对金黄色葡萄球菌、表皮葡萄球菌、肺炎球菌、溶血性链球菌、草绿色链球菌、绿脓杆菌、大肠直杆菌、变形杆菌的体外抗菌作用进行研究。体内抗菌作用采用皮下注入细菌使之形成闭合性疖肿,软膏外敷治疗验证其抗菌作用。结果:盐酸洛美沙星软膏对革兰氏阴性菌具有较强的抑菌活力,其MIC90在2mL/L附近对大肠杆菌的活力尤强,对肺炎球菌和其他链球菌的抗菌作用相对弱些,对实验性小鼠皮肤感染金黄色葡萄球菌所致闭合性疖肿有治疗作用。结论:盐酸洛美沙星软膏具有很强的抗菌活性。  相似文献   
207.
Many micropollutants, such as pharmaceuticals and other chemicals, are present globally in the aquatic environment. During effluent treatment and in the environment, transformations result in new chemicals of often unknown structure, fate, and toxicity. The design of chemicals, that can be fully mineralized or broken down into non-hazardous fragments, is considered a green chemistry approach avoiding such problems from the very beginning (“benign by design”). N-heterocycles are central lead scaffolds for many important chemicals and pharmaceuticals such as quinolines, isoquinolines, quinolones, fluoroquinolones, naphthyridones, and quinazolinones. Understanding their environmental biodegradability is mandatory for the design of greener derivatives. While the biodegradability of simple quinolines has already been reported in the literature, information on more complex azaarenes and other N-heterocycles is rather scarce.The goal of this study was to investigate the ready biodegradability of several N-heterocycles to identify biodegradable lead scaffolds. LC-HRMS studies were performed to identify possible metabolites. Out of the 84 tested substances, only 14 were readily biodegradable in either the closed bottle test (OECD 301D) or the manometric respiratory test (OECD 301F). Hydroxylation at the C2 position increased the biodegradation level of the quinolines generally and tolerated even fluorine in the molecule. Moreover, 4-oxo-1,4-dihydroquinoline-3-carboxylic acid has been tested as readily biodegradable. It is an important bioactive lead scaffold with many different applications, i.e., in antibiotics. All other quinolones containing the β-keto-carboxylic acid moiety were persistent, including their bioisosteres. The identified biodegradable scaffolds can be used to design new environmentally biodegradable molecules following green fragment-based design.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号